Signal Advisors Wealth’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Buy
6,142
+2,537
+70% +$1.07M 0.12% 145
2026
Q1
$1.71M Buy
3,605
+2,828
+364% +$1.42M 0.12% 164
2025
Q4
$363K Buy
+777
New +$361K 0.03% 366
2025
Q3
Sell
-1,082
Closed -$415K 493
2025
Q2
$415K Sell
1,082
-3,151
-74% -$1.14M 0.03% 326
2025
Q1
$1.46M Sell
4,233
-104
-2% -$33.4K 0.14% 144
2024
Q4
$1.3M Sell
4,337
-5
-0.1% -$1.75K 0.15% 148
2024
Q3
$1.76M Buy
+4,342
New +$1.59M 0.25% 96

Other funds holding HCA

Signal Advisors Wealth's HCA Position: Q2 2026 in Review

Signal Advisors Wealth increased its HCA Healthcare (HCA) stake by 70% in Q2 2026, buying an estimated $1.07M and bringing the position to 6,142 shares worth $2.39M. The position accounts for 0.12% of the portfolio, ranked #145.

Signal Advisors Wealth first reported a position in HCA in Q3 2024 and has held it in 7 quarters since. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Signal Advisors Wealth held 6,142 shares of HCA Healthcare worth $2.39M as of Q2 2026.
  • Signal Advisors Wealth bought 2,537 HCA Healthcare shares in Q2 2026, an estimated $1.07M.
  • HCA Healthcare made up 0.12% of Signal Advisors Wealth's portfolio in Q2 2026, its #145 holding.
  • Signal Advisors Wealth first reported a position in HCA Healthcare in Q3 2024 and has held it in 7 quarters since.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.